PharmaCorp Rx (TSXV:PCRX) EV-to-Revenue : 7.16 (As of Jun. 02, 2025)

PharmaCorp Rx EV-to-Revenue Chart

PharmaCorp Rx Quarterly Data
	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
EV-to-Revenue	Get a 7-Day Free Trial									-	-	-1.58	39.61	8.75

Competitive Comparison of PharmaCorp Rx's EV-to-Revenue

For the Pharmaceutical Retailers subindustry, PharmaCorp Rx's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PharmaCorp Rx's EV-to-Revenue Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, PharmaCorp Rx's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where PharmaCorp Rx's EV-to-Revenue falls into.

PharmaCorp Rx EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

PharmaCorp Rx's EV-to-Revenue for today is calculated as:

PharmaCorp Rx's current Enterprise Value is C$41.48 Mil.
PharmaCorp Rx's Revenue for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$5.79 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PharmaCorp Rx  (TSXV:PCRX) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

PharmaCorp Rx's PS Ratiofor today is calculated as:

PharmaCorp Rx's share price for today is C$0.46.
PharmaCorp Rx's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.05.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PharmaCorp Rx EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of PharmaCorp Rx's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

PharmaCorp Rx Business Description